Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Self-assembled particles for targeted delivery of immunomodulators to treat autoimmunity and cancer

Self-assembled particles for targeted delivery of immunomodulators to treat autoimmunity and cancer

US Patent 11311485 · Granted Apr 26, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Molecular entrapment via homopolymer self-assembly2025
Delivery of biomolecules to immune cells2025
Compositions and methods of using propylene sulfide-based polymers for treatment2025
Multi-subunit vaccines to elicit both MHC- and CD1-restricted T cell responses2025
Facile assembly of soft nanoarchitectures and co-loading of hydrophilic and hydr2024
Anti-polyethylene glycol (PEG) antibody mouse model for rigorous assessment of P2024
Molecular entrapment via homopolymer self-assembly2023
Compositions and methods of using propylene sulfide-based polymers for treatment2023
Multi-subunit vaccines to elicit both MHC- and CD1-restricted T cell responses2021
Facile assembly of soft nanoarchitectures and co-loading of hydrophilic and hydr2021
Delivery of biomolecules to immune cells2021
Nanostructure enhanced targeting (NSET) of inflammatory cells2020